- Home
- WTBA vs PROK Comparison
WTBA vs PROK Comparison
Compare WTBA & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | PROK |
|---|---|---|
| Founded | 1893 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.6M | 359.1M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WTBA | PROK |
|---|---|---|
| Price | $23.60 | $1.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $24.00 | $7.40 |
| AVG Volume (30 Days) | 28.8K | ★ 724.1K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 35.21 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | N/A | ★ $893,000.00 |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $9.39 | N/A |
| P/E Ratio | $38.67 | ★ N/A |
| Revenue Growth | N/A | ★ 1075.00 |
| 52 Week Low | $17.50 | $0.54 |
| 52 Week High | $26.60 | $7.13 |
Technical Indicators
Market Signals| Indicator | WTBA | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 42.76 |
| Support Level | $23.49 | $1.56 |
| Resistance Level | $24.25 | $2.58 |
| Average True Range (ATR) | 0.52 | 0.12 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 71.51 | 36.96 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.